收费全文 | 1021001篇 |
免费 | 71356篇 |
国内免费 | 1564篇 |
耳鼻咽喉 | 14324篇 |
儿科学 | 27097篇 |
妇产科学 | 25503篇 |
基础医学 | 145119篇 |
口腔科学 | 30716篇 |
临床医学 | 86166篇 |
内科学 | 204124篇 |
皮肤病学 | 21770篇 |
神经病学 | 79219篇 |
特种医学 | 38825篇 |
外国民族医学 | 81篇 |
外科学 | 163574篇 |
综合类 | 18555篇 |
现状与发展 | 1篇 |
一般理论 | 259篇 |
预防医学 | 71790篇 |
眼科学 | 23406篇 |
药学 | 79357篇 |
3篇 | |
中国医学 | 2462篇 |
肿瘤学 | 61570篇 |
2019年 | 7719篇 |
2018年 | 12037篇 |
2017年 | 8867篇 |
2016年 | 9485篇 |
2015年 | 10863篇 |
2014年 | 14102篇 |
2013年 | 20982篇 |
2012年 | 30012篇 |
2011年 | 31021篇 |
2010年 | 17891篇 |
2009年 | 16475篇 |
2008年 | 29556篇 |
2007年 | 30955篇 |
2006年 | 31556篇 |
2005年 | 30564篇 |
2004年 | 29365篇 |
2003年 | 28081篇 |
2002年 | 27311篇 |
2001年 | 57478篇 |
2000年 | 59495篇 |
1999年 | 49293篇 |
1998年 | 11191篇 |
1997年 | 9773篇 |
1996年 | 9897篇 |
1995年 | 9153篇 |
1994年 | 8479篇 |
1993年 | 7772篇 |
1992年 | 36615篇 |
1991年 | 34955篇 |
1990年 | 33690篇 |
1989年 | 32700篇 |
1988年 | 29755篇 |
1987年 | 29004篇 |
1986年 | 27010篇 |
1985年 | 25828篇 |
1984年 | 18342篇 |
1983年 | 15552篇 |
1982年 | 7995篇 |
1979年 | 16300篇 |
1978年 | 10902篇 |
1977年 | 9329篇 |
1976年 | 8159篇 |
1975年 | 8944篇 |
1974年 | 10927篇 |
1973年 | 10281篇 |
1972年 | 9721篇 |
1971年 | 9205篇 |
1970年 | 8822篇 |
1969年 | 8296篇 |
1968年 | 7574篇 |
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It includes details of the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) – PDE5 pathway in the LUT organs (bladder and prostate) in addition to the available data on tadalafil in patients with LUTS secondary to BPH with or without erectile dysfunction (ED).
Expert opinion: Preclinical and clinical data have clearly demonstrated that PDE5 inhibitors induce bladder and prostate relaxation, which contributes to the improvement seen in storage symptoms in both animal models of bladder and prostate hypercontractility. Tadalafil is effective both as a monotherapy and add-on therapy in patients with LUTS secondary to BPH. Furthermore, as LUTS-BPH and ED are urological disorders that commonly coexist in aging men, tadalafil is more advantageous than α1-adrenoceptors and should be used as the first option. Tadalafil is a safe and tolerable therapy and unlike α1- adrenoceptors and 5-alpha reductase inhibitors, which can cause sexual dysfunctions, tadalafil improves sexual function. 相似文献
Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.
Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients. 相似文献
Purpose
Endovascular treatment with mechanical thrombectomy devices demonstrated high recanalization rates but functional outcome did not correlate with high rates of recanalization obtained. Patient selection prior to the endovascular treatment is very important in the final outcome of the patient. The primary aim of our study was to evaluate the prognostic value of posterior circulation Alberta Stroke Program Early CT Score (pc-ASPECTS) and Pons-Midbrain Index (PMI) scores in patients with Basilar Artery Occlusion (BAO) treated with successful angiographic recanalization after mechanical thrombectomy.Methods
Retrospective single-center study including 18 patients between 2008 and 2013 who had acute basilar artery occlusion managed with endovascular treatment within 24 hours from symptoms onset and with successful angiographic recanalization. The patients were initially classified into two groups according to clinical outcome and mortality at 90 days. For analysis we also divided patients into groups based on pc-ASPECTS (≥8vs.< 8) and PMI (≥3vs.< 3) on non-contrast CT (NCCT) and CT Angiography Source Images (CTASI). Imaging data were correlated to clinical outcome and mortality rate.Results
CTASI pc-ASPECTS, dichotomized at < 8 versus≥8, was associated with a favorable outcome (RR: 2.6; 95% CI: 1.3-5.2) and a reduced risk of death (RR: 6.5: 95% CI: 7.8-23.3). All patients that survived and were functionally independent had pc-ASPECTS score≥8. None of the 5 patients with CTASI pc-ASPECTS score less than 8 survived.Conclusion
PC-ASPECTS on CTASI is helpful for predicting functional outcome after BAO recanalization with endovascular treatment. These results should be validated in a randomized controlled trial in order to decide whether or not to treat a patient with BAO. 相似文献Methods: Two previously published datasets (n?=?153 and n?=?641, respectively) from outpatient neuropsychological evaluations were used to test Dunham and Denney’s algorithm, and to assess concordance of failure rates with the Test of Memory Malingering and the forced choice measure of the California Verbal Learning Test, two commonly used performance validity tests.
Results: In both datasets, none of the four cutoff scores for failure on the MSVT (70%, 75%, 80%, or 85%) identified a poor validity group with proportionally aligned failure rates on other freestanding measures of performance validity. Additionally, the protocols with probable impairment did not differ from those with poor validity on cognitive measures.
Conclusions: Despite what appeared to be a promising approach to evaluating failure on the easy MSVT subtests when clinical data are unavailable (as recommended in the advanced interpretation program, or advanced interpretation [AI], of the MSVT), the current findings indicate the AI remains the gold standard for doing so. Future research should build on this effort to address shortcomings in measures of effort in neuropsychological evaluations. 相似文献